Keywords: PPV23; pneumococcal polysaccharide vaccine; PCV7; pneumococcal conjugate vaccine; IPD; invasive pneumococcal disease; ANCA; antineutrophil cytoplasmic antibody; PR3-ANCA; ANCA directed against proteinase 3; MPO-ANCA; ANCA directed against myeloperoxidase;